Business Courier: UC startup gets investment to advance trials

Sense Neuro Diagnostics’ technology can detect, monitor damage to the brain

A startup founded by four University of Cincinnati physicians has raised approximately $10 million in funding, including a recent $250,000 investment from St. Elizabeth Healthcare, the Cincinnati Business Courier reported.

Medtech startup Sense Neuro Diagnostics is developing noninvasive devices to monitor traumatic brain injuries and detect brain hemorrhage or different stroke types. The investment from St. Elizabeth Healthcare will help advance clinical trials for the technology.

“Our technology has the potential to be a total gamechanger for emergency rooms and hospital staff who treat people with traumatic brain injuries and stokes every day,” Geoff Klass, CEO of Sense Neuro Diagnostics, said.

Sense Neuro Diagnostics’ technology can collect 360 data points in 2.5 seconds. More than 20 sites in the United States, Canada and India are conducting trials of the startup’s in-hospital device while five sites are evaluating its military field device.

Read more in the Business Courier.

Featured image at top courtesy of Unsplash.

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Related Stories


Local 12: UC startup gains approval for trials

May 30, 2023

A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.